New and emerging approaches to treatment of schizophrenia

Current Neuropharmacology

Volumn 3, Issue 1, 2005, Pages 1-2

  Kinney, Gene G ^a   Conn, P Jeffrey ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE;

BINDING SITE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG TARGETING; EDITORIAL; FEMALE; HUMAN; MALE; NEUROTRANSMISSION; SCHIZOPHRENIA; SEX DIFFERENCE; SIDE EFFECT; WORKING MEMORY;

EID: 13844256068     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570159052773431     Document Type: Editorial

References (0)